Company Overview - Dabo Medical's closing price on August 19 was 57.88 yuan, down 3.06%, with a rolling PE ratio of 60.18 times and a total market value of 23.963 billion yuan [1] - The company operates in the high-value medical consumables sector, focusing on the production, research, and sales of various medical devices including intramedullary nails, external fixators, and joint prostheses [1] Financial Performance - For the first quarter of 2025, Dabo Medical reported revenue of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, up 67.04%, with a gross profit margin of 69.64% [1] Industry Comparison - The average PE ratio for the medical device industry is 59.49 times, with a median of 40.19 times, placing Dabo Medical at the 89th position in the industry ranking [1] - The company has a total of 9 institutional investors holding shares, with a combined holding of 4.8226 million shares valued at 175 million yuan [1] Market Position - Dabo Medical's PE ratio is higher than the industry average and median, indicating a premium valuation compared to peers [2] - The company is positioned within a competitive landscape, with various other medical device companies having lower PE ratios, such as Jiuan Medical at 11.65 times and Yiyue Medical at 20.37 times [2]

Core Viewpoint - The stock of Dabo Medical (002901) has shown a price increase of 3.35% as of August 15, 2025, closing at 59.21 yuan, with significant trading activity and mixed fund flows [1][2]. Group 1: Stock Performance and Fund Flows - On August 15, 2025, Dabo Medical's stock price increased by 3.35%, with a trading volume of 81,000 hands and a total transaction amount of 476 million yuan [1]. - The fund flow data indicates a net outflow of 7.05 million yuan from institutional investors, accounting for 1.48% of the total transaction amount, while retail investors saw a net inflow of 14.92 million yuan, representing 3.14% of the total [1][2]. - Over the past five days, the stock experienced fluctuations, with a notable drop of 7.36% on August 14, 2025, followed by a recovery on August 15 [2]. Group 2: Company Financials and Industry Comparison - Dabo Medical's total market capitalization is 24.514 billion yuan, significantly higher than the industry average of 11.953 billion yuan, ranking 9th in the industry [3]. - The company reported a net profit of 1.03 billion yuan for the first quarter of 2025, reflecting a year-on-year increase of 67.04%, with a gross margin of 69.64% [3]. - The company's price-to-earnings ratio (P/E) stands at 59.44, which is lower than the industry average of 75.58, indicating a relatively favorable valuation [3].

Group 1 - The core viewpoint of the articles highlights that Dabo Medical's stock closed at 59.21 yuan, with a 3.35% increase, and a rolling PE ratio of 61.56 times, leading to a total market capitalization of 24.514 billion yuan [1] - The average PE ratio for the medical device industry is 56.58 times, with a median of 39.97 times, positioning Dabo Medical at the 90th rank within the industry [1] - Dabo Medical's main business involves the production, research, and sales of high-value medical consumables, including a wide range of orthopedic and surgical products [1] Group 2 - The latest quarterly report for Q1 2025 shows that Dabo Medical achieved an operating revenue of 550 million yuan, representing a year-on-year increase of 28.80%, and a net profit of 103 million yuan, with a year-on-year growth of 67.04% [1] - The sales gross margin for Dabo Medical stands at 69.64% [1] - The company experienced a net outflow of 7.0504 million yuan in principal funds on August 15, with a total outflow of 131.9464 million yuan over the past five days [1]

大博医疗主营业务：医用高值耗材的生产、研发与销售。 截至2025年3月31日，大博医疗实现营业总收入5.50亿元，同比增长28.80%，实现归属净利润1.03亿 元，同比增长67.04%。流动比率、速动比率分别为3.211、1.785，资产负债率为25.96%。 来源：金融界 8月15日收盘，大博医疗当日上涨3.35%，成交额4.76亿元，换手率2.81%。从区间来看，该股近10个交 易日累计上涨32.52%。 资金流向方面，今日主力资金净流出705.04万元，占成交比1.48%，其中超大单净流入2393.96万元，占 成交比5.03%。 ...

Core Viewpoint - Dabo Medical's stock closed at 57.29 yuan on August 14, experiencing a decline of 7.36%, with a rolling PE ratio of 59.57 times and a total market capitalization of 23.719 billion yuan [1] Company Summary - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with key products including intramedullary nails, hollow nails, ordinary plates, locking plates, external fixators, bone needles, spinal fixation devices, and various joint prostheses [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, a year-on-year increase of 67.04%, with a gross profit margin of 69.64% [1] Industry Summary - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, placing Dabo Medical at the 90th position in the industry ranking [1] - The company’s PE (TTM) is 59.57, while the industry average is 55.76, indicating that Dabo Medical is trading at a premium compared to its peers [2] - The total market capitalization of Dabo Medical is 23.719 billion yuan, which is significantly higher than the industry median market capitalization of 5.679 billion yuan [2]

证券之星消息，8月14日医疗器械板块较上一交易日下跌2.16%，利德曼领跌。当日上证指数报收于 3666.44，下跌0.46%。深证成指报收于11451.43，下跌0.87%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300289 | 利德曼 | 10.06 | -11.21% | 106.05万 | | 10.85 Z | | 300981 | 中红医疗 | 16.00 | -9.91% | 26.13万 | | 4.31亿 | | 688677 | 海泰新光 | 45.30 | -7.93% | 4.91万 | | 2.28亿 | | 301235 | や康浩浄 | 29.72 | -7.90% | 15.14万 | | 4.42亿 | | 832278 | 鹿得医疗 | 11.23 | -7.88% | 9.33万 | | 1.07亿 | | 688212 | 澳华内镜 | 49.14 | -7.79% | 4.70万 | | 2.34亿 ...

Core Viewpoint - Dabo Medical's stock closed at 61.84 yuan on August 13, with a PE ratio of 64.30, indicating a higher valuation compared to the industry average [1] Company Summary - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, including a wide range of orthopedic and surgical products [1] - The latest quarterly report for Q1 2025 shows a revenue of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, up 67.04%, with a gross margin of 69.64% [1] Industry Summary - The average PE ratio for the medical device industry is 57.48, with a median of 40.95, positioning Dabo Medical at the 90th rank within the industry [2] - The total market capitalization of Dabo Medical is 25.603 billion yuan, which is significantly higher than the industry average market cap of 12.064 billion yuan [2]

Group 1 - The latest stock price of Dabo Medical is 61.06 yuan, an increase of 2.31 yuan from the previous trading day, with a highest intraday price of 62.00 yuan and a lowest of 57.03 yuan, totaling a trading volume of 110,229 hands and a transaction amount of 653 million yuan [1] - Dabo Medical operates in the medical device industry, focusing on the research, production, and sales of orthopedic implant medical consumables, including trauma, spine, and joint implants, as well as surgical instruments [1] - On August 11, Dabo Medical experienced a rapid price increase, rising over 2% within 5 minutes, with a stock price of 59.23 yuan reported at 9:52 AM and a transaction amount reaching 190 million yuan at that time [1] Group 2 - The net inflow of main funds on that day was 82,300 yuan, with a cumulative net inflow of 7.6393 million yuan over the past five trading days [1] - The current total market capitalization of the company is 25.28 billion yuan, with a circulating market capitalization of 17.617 billion yuan [1]

证券之星消息，截至2025年8月8日收盘，大博医疗(002901)报收于58.75元，上涨2.35%，换手率 5.16%，成交量14.88万手，成交额8.59亿元。 8月8日的资金流向数据方面，主力资金净流出818.97万元，占总成交额0.95%，游资资金净流出4.82万 元，占总成交额0.01%，散户资金净流入823.79万元，占总成交额0.96%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-08 | 58.75 | 2.35% | -818.97万 | -0.95% | -4.82万 | -0.01% | 823.79万 | - 0.96% | | 2025-08-07 | | 57.40 10.00% | 7125.12万 | 11.05% | -2380.94万 | -3.69% | -4744.18万 | -7.35% | | 2025-08-06 | 52.18 ...

Summary of Key Points Core Viewpoint - Dabo Medical (002901) experienced a significant increase in stock price, closing at 57.4 yuan with a 10.0% rise, indicating strong market interest and performance on August 7, 2025 [1] Trading Information - The stock reached its daily limit at 10:27 AM and maintained this status until market close [1] - The trading volume was 116,500 hands, with a total transaction value of 645 million yuan [1] - The net inflow of main funds was 71.25 million yuan, while retail investors saw a net outflow of 47.44 million yuan [1] - The closing order amount was 36.59 million yuan, representing 0.22% of the company's circulating market value [1]